Closing Bell: Fennec Pharmaceuticals Inc up on Thursday (FRX)

Fennec Pharmaceuticals Inc opened trading today at $9.08 and closed at $9.08. Intraday prices ranged from a low of $9.08 to a high of $9.08.

Share prices raised 0.44% from the previous day's close of $9.04.

During the day across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.

Trading volume was 125 on 2 total trades, with an average volume of 1,145 over the last 5 days.

The TSX overall saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have reduced -19.43% in the last year, while they have shrunken -40.11% this year.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $246.99 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Based on 6.00 analysts, Fennec Pharmaceuticals Inc gets an average recommendation of "Strong Buy" according to Zacks. Currently, there are 6 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..